CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Verywell Health on MSN2d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant DepressionPeople with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
I’ve been living with depression for almost 12 years. I’m 31 now and I found out I had major depressive disorder when I was 19. I had a miserable freshman year of college, but I didn't really ...
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
Takeda is taking back the home license for a phase 3-stage depression drug as part of an amendment to its multi-asset ...
Medical Xpress on MSN9d
Drawing a Line From the Gut Microbiome to Inflammation and DepressionBiochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some ...
Neurocrine Biosciences advances Phase 3 plans for osavampator after achieving Phase 2 success in major depressive disorder, amending its Takeda deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback